Analysis of Gut-Homing Receptors in Circulating Mucosal-Associated Invariant T Cells and Their Presence in Synovial Tissue From Patients With Axial Spondyloarthritis

Citrullinated peptides of peptidyl arginine deiminase 4 as major B-cell epitopes in patients with rheumatoid arthritis

Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume III

Concordance and agreement between different activity scores in polymyalgia rheumatica

Areal bone mineral density, trabecular bone score and 3D-DXA analysis of proximal femur in psoriatic disease

Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II

Editorial: Impact and consequences of COVID-19 on the musculoskeletal system

Current Pharmacological Therapies for the Management of Spondyloarthritis: Special Considerations in Older Patients

Advances in pharmacotherapies for axial spondyloarthritis

The Influence of Adipokines on Radiographic Damage in Inflammatory Rheumatic Diseases

The cardiometabolic conditions of psoriatic disease

The Use of Janus Kinase Inhibitors in Axial Spondyloarthritis: Current Insights

Characterization of mucosal-associated invariant T cells in blood of patients with axial spondyloarthritis and in axial entheses of healthy controls: comment on the article by Rosine et al

Lack of association between the TNFAIP3 rs2230926 variant and rheumatoid arthritis-associated lymphoma

Editorial: Recent Advances in Potential Biomarkers for Rheumatic Diseases and in Cell-Based Therapies in the Management of Inflammatory Rheumatic Diseases

Sustained remission of ankylosing spondylitis following intravesical Bacillus Calmette et Guérin immunotherapy for bladder cancer

Lymphoma complicating rheumatoid arthritis: results from a French case-control study

Convalescent plasma to treat COVID-19: Following the Argentinian lead

The Risk of Cardiovascular Diseases in Axial Spondyloarthritis. Current Insights

Spondyloarthritis-Associated IgA Nephropathy

L5 Radiculopathy with Neurological Deficit Due To Sacral Insufficiency Fracture

An unusual association of CANOMAD and rheumatoid arthritis with a long-term follow-up

The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition

Pharmacological management of axial spondyloarthritis in adults

Unilateral Accessory Sacroiliac Joint with Bone Marrow Edema Mimicking Sacroiliitis

Increased IL-22- and IL-17A-Producing Mucosal-Associated Invariant T Cells in the Peripheral Blood of Patients With Ankylosing Spondylitis

Could Sodium Chloride be an Environmental Trigger for Immune-Mediated Diseases? An Overview of the Experimental and Clinical Evidence

Anti-neutrophil cytoplasmic antibody-associated chronic inflammatory arthritis without vasculitis. Data from a French nationwide survey

Harnessing Apoptotic Cell Clearance to Treat Autoimmune Arthritis

Serum adipokines, adipose tissue measurements and metabolic parameters in patients with advanced radiographic knee osteoarthritis

Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica

Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial

Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica

Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study

Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case series

Tocilizumab failure in malignancy-related polymyalgia rheumatica

Bone health in Parkinson's disease: a comprehensive review of bone involvement and its pathophysiological mechanisms

Fractures reduction with osteoporotic treatments in patients over 75-year-old: A systematic review and meta-analysis

Mini-Review: The Administration of Apoptotic Cells for Treating Rheumatoid Arthritis: Current Knowledge and Clinical Perspectives

Mini-Review: The Contribution of Adipokines to Joint Inflammation in Inflammatory Rheumatic Diseases

IL-17 inhibitors in axial spondyloarthritis. An overview

Ixekizumab: an anti- IL-17A monoclonal antibody for the treatment of psoriatic arthritis

MAIT cells: potent major cellular players in the IL-17 pathway of spondyloarthritis?

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial

Safety of the use of anti-IL17A treatment in a patient with certolizumab-induced sarcoidosis

ATHLETIQUE: interest of an adapted physical activity program in patients with juvenile idiopathic arthritis: a feasibility and preliminary effectiveness study

A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn's disease receiving methotrexate therapy

Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry

Fractures reduction with osteoporotic treatments in patients over 75-year-old: A systematic review and meta-analysis

Visceral adiposity in patients with psoriatic arthritis and psoriasis alone and its relationship with metabolic and cardiovascular risk